ACE2 and acute respiratory distress syndrome: Bone marrow-derived mesenchymal stem cells (MSCs) with ACE2 overexpression were used as a vehicle for gene therapy in ARDS mice induced by lipopolysaccharide (LPS; He et al., 2015).